Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A long term, open label, randomised study in patients with type 2 diabetes, comparing the combination of rosiglitazone and either metformin or sulfonylurea with metformin plus sulfonylurea on cardiovascular endpoints and glycaemia
rosiglitazone
49653/231
NCT00379769
Diabetes Mellitus, Type 2
Phase 3
 
September 2013

Powered by ideaPoint, Inc.